Diseases · Entity Annotation Prototype (beta)

199articles mentioning diseases

861disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: HCC ×

HCC

This disease is selected. Its supporting articles are shown below.

HCC199

Articles mentioning HCC

199 articles · page 4 of 17

49 Complement system alterations in hepatocellular carcinoma (HCC): insights from mRNA-proteome integration and receptor blockade studies

jitc · abstract · 2025-11-04 · 7 matching annotations

93.1%

hepatocellular carcinoma HCC liver cancer cancer C3aR-AT

…Background Despite recent advances, hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, part…

P62 Evaluating current hepatocellular carcinoma (HCC) surveillance practice in a regional HCC multidisciplinary team: a clinical audit

gutjnl · abstract · 2025-10-06 · 7 matching annotations

90.1%

Hepatocellular carcinoma hepatitis B cirrhosis HCC curative treatment

…Introduction Hepatocellular carcinoma (HCC) incidence in the UK has increased by 50% over the past de…

Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis

bmjgast · abstract · 2026-07-17 · 6 matching annotations

91.1%

hepatocellular carcinoma cirrhosis HCC

…Objective For surveillance for hepatocellular carcinoma (HCC) to be effective, tests—including imaging, serological bio…

IDDF2026-ABS-0094 Clinical outcomes and safety of GPC3-directed CAR-T therapy in advanced hepatocellular carcinoma: a systematic review of early-phase trials

gutjnl · abstract · 2026-06-26 · 6 matching annotations

88.4%

Hepatocellular carcinoma HCC PubMed GPC3 Chimeric antigen receptor T-cell (CAR-T) therapy Glypican-3 GPC3-directed CAR-T therapy Google Scholar

…Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality world…

IDDF2026-ABS-0381 Diminished alpha-adrenergic neuro-immune signaling drives hepatocellular carcinoma recurrence post-liver transplantation

gutjnl · abstract · 2026-06-26 · 6 matching annotations

92.3%

HCC hepatocellular carcinoma Queen Mary Hospital Liver transplantation TCGA

…condary surgery for recurrent disease. In vivo, a C57BL/6 mouse HCC model mapped the 3D spatial distribution of hepatic nerves and …

O10 ELUCIDATE trial: non-invasive tests to detect and direct cirrhosis management do not improve survival or the incidence of severe decompensation

gutjnl · abstract · 2026-06-23 · 6 matching annotations

92.7%

Cirrhosis HCC hepatocellular cancer portal hypertension PHTN FSCC

…Introduction Cirrhosis is often diagnosed late, limiting opportunities for surveillanc…

O8 SHiNE-UK: a national evaluation of hepatocellular carcinoma surveillance, routes to diagnosis and treatment utilisation

gutjnl · abstract · 2026-06-23 · 6 matching annotations

89.1%

HCC Hepatocellular carcinoma cirrhosis BCLC 0-A BCLC LI-RADS

…tations. This study aims to evaluate the performance of current HCC pathways in the UK.Methods A multi-centre retrospective study w…

12-HETE: a novel lipid mediator of CD8+ T cell dysfunction in MASH/HCC

gutjnl · abstract · 2026-05-17 · 6 matching annotations

90.2%

Hepatocellular carcinoma HCC IL-15

…Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortalit…

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study

gutjnl · abstract · 2026-03-30 · 6 matching annotations

90.5%

hepatocellular carcinoma HCC The Cancer Genome Atlas TCGA TACE TACE therapy

…l outcomes after transarterial chemoembolisation (TACE) vary in hepatocellular carcinoma (HCC) patients, and existing prognostic scores and imaging mode…

5PSQ-158 Autoimmune pneumonitis as a fatal adverse reaction to durvalumab and tremelimumab in advanced hepatocellular carcinoma: a case report

ejhpharm · abstract · 2026-03-18 · 6 matching annotations

89.8%

HCC hepatocellular carcinoma durvalumab tremelimumab apixaban methylprednisolone

…essment in 05/2025 did not reveal significant coronary disease. HCC revaluation after TARE showed disease progression.Material and …

Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma

gutjnl · abstract · 2026-02-09 · 6 matching annotations

95.9%

hepatocellular carcinoma HCC atezolizumab bevacizumab NCT04649489

…) therapy has significantly advanced therapeutic approaches for hepatocellular carcinoma (HCC). However, less than 30% of patients achieve durable respo…

Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis

jitc · abstract · 2026-01-27 · 6 matching annotations

88.2%

Hepatocellular carcinoma HCC C7orf50 T-cell receptor (TCR)-T cell therapy

…Background Hepatocellular carcinoma (HCC) is a global health challenge with high mortality rates, p…

Browse diseases

HCC

Articles mentioning HCC